nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclosporine—ABCC10—Doxorubicin—liver cancer	0.0802	0.147	CbGbCtD
Cyclosporine—ABCC1—Epirubicin—liver cancer	0.0583	0.107	CbGbCtD
Cyclosporine—ABCC3—Doxorubicin—liver cancer	0.0504	0.0925	CbGbCtD
Cyclosporine—ABCB11—Doxorubicin—liver cancer	0.0436	0.08	CbGbCtD
Cyclosporine—ABCC2—Sorafenib—liver cancer	0.0378	0.0693	CbGbCtD
Cyclosporine—ABCG2—Sorafenib—liver cancer	0.0342	0.0627	CbGbCtD
Cyclosporine—ABCC1—Doxorubicin—liver cancer	0.031	0.0568	CbGbCtD
Cyclosporine—SLC10A1—bile canaliculus—liver cancer	0.026	0.174	CbGeAlD
Cyclosporine—ABCB11—bile canaliculus—liver cancer	0.0257	0.172	CbGeAlD
Cyclosporine—CYP3A7—Sorafenib—liver cancer	0.0252	0.0463	CbGbCtD
Cyclosporine—CYP3A7-CYP3A51P—Sorafenib—liver cancer	0.0252	0.0463	CbGbCtD
Cyclosporine—ABCC2—Doxorubicin—liver cancer	0.0229	0.0421	CbGbCtD
Cyclosporine—ABCG2—Doxorubicin—liver cancer	0.0207	0.038	CbGbCtD
Cyclosporine—CYP3A5—Sorafenib—liver cancer	0.0189	0.0347	CbGbCtD
Cyclosporine—CYP2C8—Sorafenib—liver cancer	0.0182	0.0334	CbGbCtD
Cyclosporine—CYP2C19—Sorafenib—liver cancer	0.0153	0.028	CbGbCtD
Cyclosporine—SLC10A2—bile duct—liver cancer	0.015	0.1	CbGeAlD
Cyclosporine—ABCC2—bile canaliculus—liver cancer	0.0131	0.0874	CbGeAlD
Cyclosporine—CYP2C9—Sorafenib—liver cancer	0.0127	0.0233	CbGbCtD
Cyclosporine—ABCB1—Sorafenib—liver cancer	0.0123	0.0226	CbGbCtD
Cyclosporine—CYP2D6—Sorafenib—liver cancer	0.0116	0.0213	CbGbCtD
Cyclosporine—SLC10A2—bile—liver cancer	0.0115	0.0771	CbGeAlD
Cyclosporine—SLC10A1—bile duct—liver cancer	0.00811	0.0543	CbGeAlD
Cyclosporine—ABCB11—bile duct—liver cancer	0.00802	0.0537	CbGeAlD
Cyclosporine—ABCB1—Doxorubicin—liver cancer	0.00747	0.0137	CbGbCtD
Cyclosporine—CYP3A4—Sorafenib—liver cancer	0.00738	0.0135	CbGbCtD
Cyclosporine—CYP2D6—Doxorubicin—liver cancer	0.00704	0.0129	CbGbCtD
Cyclosporine—SLC10A1—bile—liver cancer	0.00623	0.0418	CbGeAlD
Cyclosporine—ABCB11—bile—liver cancer	0.00616	0.0413	CbGeAlD
Cyclosporine—ABCC3—bile duct—liver cancer	0.0051	0.0342	CbGeAlD
Cyclosporine—CYP3A4—Doxorubicin—liver cancer	0.00448	0.00821	CbGbCtD
Cyclosporine—ABCC2—bile duct—liver cancer	0.00408	0.0273	CbGeAlD
Cyclosporine—ABCC2—bile—liver cancer	0.00313	0.021	CbGeAlD
Cyclosporine—PPIB—gall bladder—liver cancer	0.00202	0.0136	CbGeAlD
Cyclosporine—FKBP4—embryo—liver cancer	0.00201	0.0135	CbGeAlD
Cyclosporine—FKBP1B—liver—liver cancer	0.0014	0.00941	CbGeAlD
Cyclosporine—ABCC3—gall bladder—liver cancer	0.00109	0.00729	CbGeAlD
Cyclosporine—FKBP4—liver—liver cancer	0.000929	0.00622	CbGeAlD
Cyclosporine—PPID—liver—liver cancer	0.000857	0.00574	CbGeAlD
Cyclosporine—CAMLG—liver—liver cancer	0.000845	0.00566	CbGeAlD
Cyclosporine—PPIA—liver—liver cancer	0.00077	0.00515	CbGeAlD
Cyclosporine—PPIF—liver—liver cancer	0.000623	0.00417	CbGeAlD
Cyclosporine—PPP3CA—liver—liver cancer	0.000597	0.004	CbGeAlD
Cyclosporine—PPIB—liver—liver cancer	0.000593	0.00397	CbGeAlD
Cyclosporine—SLC10A1—liver—liver cancer	0.000507	0.0034	CbGeAlD
Cyclosporine—ABCB11—liver—liver cancer	0.000502	0.00336	CbGeAlD
Cyclosporine—CYP3A7—liver—liver cancer	0.000491	0.00329	CbGeAlD
Cyclosporine—CYP3A7-CYP3A51P—liver—liver cancer	0.000417	0.00279	CbGeAlD
Cyclosporine—FKBP1A—liver—liver cancer	0.000396	0.00266	CbGeAlD
Cyclosporine—SLCO1B1—liver—liver cancer	0.000336	0.00225	CbGeAlD
Cyclosporine—ABCC3—liver—liver cancer	0.000319	0.00214	CbGeAlD
Cyclosporine—ABCC10—liver—liver cancer	0.000318	0.00213	CbGeAlD
Cyclosporine—SLCO1A2—liver—liver cancer	0.000274	0.00183	CbGeAlD
Cyclosporine—ABCC2—liver—liver cancer	0.000255	0.00171	CbGeAlD
Cyclosporine—ABCC1—liver—liver cancer	0.000225	0.0015	CbGeAlD
Cyclosporine—Body temperature increased—Sorafenib—liver cancer	0.000223	0.00159	CcSEcCtD
Cyclosporine—Renal impairment—Epirubicin—liver cancer	0.000222	0.00159	CcSEcCtD
Cyclosporine—Dermatitis bullous—Epirubicin—liver cancer	0.000221	0.00158	CcSEcCtD
Cyclosporine—Purpura—Epirubicin—liver cancer	0.00022	0.00157	CcSEcCtD
Cyclosporine—CYP2C19—liver—liver cancer	0.000219	0.00147	CbGeAlD
Cyclosporine—Vascular purpura—Doxorubicin—liver cancer	0.000219	0.00156	CcSEcCtD
Cyclosporine—Anaphylactoid reaction—Epirubicin—liver cancer	0.000219	0.00156	CcSEcCtD
Cyclosporine—Hepatic failure—Doxorubicin—liver cancer	0.000218	0.00156	CcSEcCtD
Cyclosporine—Eczema—Doxorubicin—liver cancer	0.000218	0.00156	CcSEcCtD
Cyclosporine—Eye pain—Doxorubicin—liver cancer	0.000217	0.00155	CcSEcCtD
Cyclosporine—Hypoglycaemia—Epirubicin—liver cancer	0.000217	0.00155	CcSEcCtD
Cyclosporine—Cardiac failure—Epirubicin—liver cancer	0.000217	0.00155	CcSEcCtD
Cyclosporine—Lethargy—Epirubicin—liver cancer	0.000216	0.00154	CcSEcCtD
Cyclosporine—Osteoarthritis—Epirubicin—liver cancer	0.000212	0.00151	CcSEcCtD
Cyclosporine—Hot flush—Doxorubicin—liver cancer	0.000209	0.00149	CcSEcCtD
Cyclosporine—Increased appetite—Doxorubicin—liver cancer	0.000208	0.00149	CcSEcCtD
Cyclosporine—Migraine—Epirubicin—liver cancer	0.000208	0.00149	CcSEcCtD
Cyclosporine—Affect lability—Epirubicin—liver cancer	0.000208	0.00149	CcSEcCtD
Cyclosporine—Menopausal symptoms—Doxorubicin—liver cancer	0.000208	0.00148	CcSEcCtD
Cyclosporine—Hypersensitivity—Sorafenib—liver cancer	0.000207	0.00148	CcSEcCtD
Cyclosporine—Renal impairment—Doxorubicin—liver cancer	0.000206	0.00147	CcSEcCtD
Cyclosporine—Dermatitis bullous—Doxorubicin—liver cancer	0.000205	0.00146	CcSEcCtD
Cyclosporine—Purpura—Doxorubicin—liver cancer	0.000203	0.00145	CcSEcCtD
Cyclosporine—Anaphylactoid reaction—Doxorubicin—liver cancer	0.000202	0.00144	CcSEcCtD
Cyclosporine—Asthenia—Sorafenib—liver cancer	0.000202	0.00144	CcSEcCtD
Cyclosporine—Hypoglycaemia—Doxorubicin—liver cancer	0.000201	0.00143	CcSEcCtD
Cyclosporine—Cardiac failure—Doxorubicin—liver cancer	0.000201	0.00143	CcSEcCtD
Cyclosporine—Mood swings—Epirubicin—liver cancer	0.000201	0.00143	CcSEcCtD
Cyclosporine—Lethargy—Doxorubicin—liver cancer	0.0002	0.00143	CcSEcCtD
Cyclosporine—Pruritus—Sorafenib—liver cancer	0.000199	0.00142	CcSEcCtD
Cyclosporine—ABCB1—embryo—liver cancer	0.000198	0.00133	CbGeAlD
Cyclosporine—Blood creatinine increased—Epirubicin—liver cancer	0.000198	0.00142	CcSEcCtD
Cyclosporine—Osteoarthritis—Doxorubicin—liver cancer	0.000196	0.0014	CcSEcCtD
Cyclosporine—Dry skin—Epirubicin—liver cancer	0.000194	0.00139	CcSEcCtD
Cyclosporine—Abdominal pain upper—Epirubicin—liver cancer	0.000193	0.00138	CcSEcCtD
Cyclosporine—Affect lability—Doxorubicin—liver cancer	0.000193	0.00138	CcSEcCtD
Cyclosporine—Migraine—Doxorubicin—liver cancer	0.000193	0.00138	CcSEcCtD
Cyclosporine—Diarrhoea—Sorafenib—liver cancer	0.000193	0.00138	CcSEcCtD
Cyclosporine—CYP2C8—liver—liver cancer	0.000191	0.00128	CbGeAlD
Cyclosporine—Breast disorder—Epirubicin—liver cancer	0.000191	0.00137	CcSEcCtD
Cyclosporine—Gastritis—Epirubicin—liver cancer	0.000187	0.00134	CcSEcCtD
Cyclosporine—Muscular weakness—Epirubicin—liver cancer	0.000187	0.00133	CcSEcCtD
Cyclosporine—Dizziness—Sorafenib—liver cancer	0.000186	0.00133	CcSEcCtD
Cyclosporine—ABCG2—liver—liver cancer	0.000186	0.00125	CbGeAlD
Cyclosporine—Mood swings—Doxorubicin—liver cancer	0.000186	0.00132	CcSEcCtD
Cyclosporine—Abdominal distension—Epirubicin—liver cancer	0.000184	0.00132	CcSEcCtD
Cyclosporine—Blood creatinine increased—Doxorubicin—liver cancer	0.000183	0.00131	CcSEcCtD
Cyclosporine—Dysphagia—Epirubicin—liver cancer	0.000183	0.00131	CcSEcCtD
Cyclosporine—Dry skin—Doxorubicin—liver cancer	0.00018	0.00128	CcSEcCtD
Cyclosporine—Pancreatitis—Epirubicin—liver cancer	0.000179	0.00128	CcSEcCtD
Cyclosporine—Vomiting—Sorafenib—liver cancer	0.000179	0.00128	CcSEcCtD
Cyclosporine—Abdominal pain upper—Doxorubicin—liver cancer	0.000179	0.00128	CcSEcCtD
Cyclosporine—Rash—Sorafenib—liver cancer	0.000177	0.00127	CcSEcCtD
Cyclosporine—Dermatitis—Sorafenib—liver cancer	0.000177	0.00127	CcSEcCtD
Cyclosporine—Breast disorder—Doxorubicin—liver cancer	0.000177	0.00126	CcSEcCtD
Cyclosporine—Headache—Sorafenib—liver cancer	0.000176	0.00126	CcSEcCtD
Cyclosporine—Bronchitis—Epirubicin—liver cancer	0.000176	0.00126	CcSEcCtD
Cyclosporine—Gastritis—Doxorubicin—liver cancer	0.000173	0.00124	CcSEcCtD
Cyclosporine—Muscular weakness—Doxorubicin—liver cancer	0.000173	0.00123	CcSEcCtD
Cyclosporine—CYP3A5—liver—liver cancer	0.000173	0.00116	CbGeAlD
Cyclosporine—Dysuria—Epirubicin—liver cancer	0.000171	0.00122	CcSEcCtD
Cyclosporine—Abdominal distension—Doxorubicin—liver cancer	0.00017	0.00122	CcSEcCtD
Cyclosporine—Upper respiratory tract infection—Epirubicin—liver cancer	0.00017	0.00121	CcSEcCtD
Cyclosporine—CYP2C9—liver—liver cancer	0.00017	0.00114	CbGeAlD
Cyclosporine—Dysphagia—Doxorubicin—liver cancer	0.000169	0.00121	CcSEcCtD
Cyclosporine—Pollakiuria—Epirubicin—liver cancer	0.000169	0.00121	CcSEcCtD
Cyclosporine—Nausea—Sorafenib—liver cancer	0.000167	0.00119	CcSEcCtD
Cyclosporine—Weight increased—Epirubicin—liver cancer	0.000166	0.00119	CcSEcCtD
Cyclosporine—Pancreatitis—Doxorubicin—liver cancer	0.000166	0.00119	CcSEcCtD
Cyclosporine—Weight decreased—Epirubicin—liver cancer	0.000166	0.00118	CcSEcCtD
Cyclosporine—Hyperglycaemia—Epirubicin—liver cancer	0.000165	0.00118	CcSEcCtD
Cyclosporine—Pneumonia—Epirubicin—liver cancer	0.000164	0.00117	CcSEcCtD
Cyclosporine—Infestation NOS—Epirubicin—liver cancer	0.000163	0.00116	CcSEcCtD
Cyclosporine—Infestation—Epirubicin—liver cancer	0.000163	0.00116	CcSEcCtD
Cyclosporine—Bronchitis—Doxorubicin—liver cancer	0.000163	0.00116	CcSEcCtD
Cyclosporine—Renal failure—Epirubicin—liver cancer	0.00016	0.00114	CcSEcCtD
Cyclosporine—Neuropathy peripheral—Epirubicin—liver cancer	0.00016	0.00114	CcSEcCtD
Cyclosporine—Stomatitis—Epirubicin—liver cancer	0.000159	0.00114	CcSEcCtD
Cyclosporine—Jaundice—Epirubicin—liver cancer	0.000159	0.00114	CcSEcCtD
Cyclosporine—Conjunctivitis—Epirubicin—liver cancer	0.000159	0.00113	CcSEcCtD
Cyclosporine—Urinary tract infection—Epirubicin—liver cancer	0.000159	0.00113	CcSEcCtD
Cyclosporine—Dysuria—Doxorubicin—liver cancer	0.000158	0.00113	CcSEcCtD
Cyclosporine—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000157	0.00112	CcSEcCtD
Cyclosporine—Pollakiuria—Doxorubicin—liver cancer	0.000156	0.00112	CcSEcCtD
Cyclosporine—Haematuria—Epirubicin—liver cancer	0.000156	0.00111	CcSEcCtD
Cyclosporine—Hepatobiliary disease—Epirubicin—liver cancer	0.000154	0.0011	CcSEcCtD
Cyclosporine—Weight increased—Doxorubicin—liver cancer	0.000154	0.0011	CcSEcCtD
Cyclosporine—Epistaxis—Epirubicin—liver cancer	0.000154	0.0011	CcSEcCtD
Cyclosporine—Weight decreased—Doxorubicin—liver cancer	0.000153	0.00109	CcSEcCtD
Cyclosporine—Sinusitis—Epirubicin—liver cancer	0.000153	0.00109	CcSEcCtD
Cyclosporine—Hyperglycaemia—Doxorubicin—liver cancer	0.000153	0.00109	CcSEcCtD
Cyclosporine—Pneumonia—Doxorubicin—liver cancer	0.000152	0.00108	CcSEcCtD
Cyclosporine—Infestation NOS—Doxorubicin—liver cancer	0.000151	0.00108	CcSEcCtD
Cyclosporine—Infestation—Doxorubicin—liver cancer	0.000151	0.00108	CcSEcCtD
Cyclosporine—Renal failure—Doxorubicin—liver cancer	0.000148	0.00106	CcSEcCtD
Cyclosporine—Neuropathy peripheral—Doxorubicin—liver cancer	0.000148	0.00106	CcSEcCtD
Cyclosporine—Haemoglobin—Epirubicin—liver cancer	0.000147	0.00105	CcSEcCtD
Cyclosporine—Stomatitis—Doxorubicin—liver cancer	0.000147	0.00105	CcSEcCtD
Cyclosporine—Jaundice—Doxorubicin—liver cancer	0.000147	0.00105	CcSEcCtD
Cyclosporine—Rhinitis—Epirubicin—liver cancer	0.000147	0.00105	CcSEcCtD
Cyclosporine—Conjunctivitis—Doxorubicin—liver cancer	0.000147	0.00105	CcSEcCtD
Cyclosporine—Urinary tract infection—Doxorubicin—liver cancer	0.000147	0.00105	CcSEcCtD
Cyclosporine—Haemorrhage—Epirubicin—liver cancer	0.000146	0.00105	CcSEcCtD
Cyclosporine—Hepatitis—Epirubicin—liver cancer	0.000146	0.00105	CcSEcCtD
Cyclosporine—Hypoaesthesia—Epirubicin—liver cancer	0.000146	0.00104	CcSEcCtD
Cyclosporine—Pharyngitis—Epirubicin—liver cancer	0.000145	0.00104	CcSEcCtD
Cyclosporine—Urinary tract disorder—Epirubicin—liver cancer	0.000145	0.00103	CcSEcCtD
Cyclosporine—Haematuria—Doxorubicin—liver cancer	0.000144	0.00103	CcSEcCtD
Cyclosporine—Connective tissue disorder—Epirubicin—liver cancer	0.000144	0.00103	CcSEcCtD
Cyclosporine—Urethral disorder—Epirubicin—liver cancer	0.000144	0.00102	CcSEcCtD
Cyclosporine—Hepatobiliary disease—Doxorubicin—liver cancer	0.000143	0.00102	CcSEcCtD
Cyclosporine—Epistaxis—Doxorubicin—liver cancer	0.000142	0.00102	CcSEcCtD
Cyclosporine—Sinusitis—Doxorubicin—liver cancer	0.000142	0.00101	CcSEcCtD
Cyclosporine—Visual impairment—Epirubicin—liver cancer	0.000141	0.00101	CcSEcCtD
Cyclosporine—Tinnitus—Epirubicin—liver cancer	0.000137	0.000975	CcSEcCtD
Cyclosporine—Haemoglobin—Doxorubicin—liver cancer	0.000136	0.000972	CcSEcCtD
Cyclosporine—Flushing—Epirubicin—liver cancer	0.000136	0.00097	CcSEcCtD
Cyclosporine—Rhinitis—Doxorubicin—liver cancer	0.000136	0.00097	CcSEcCtD
Cyclosporine—Hepatitis—Doxorubicin—liver cancer	0.000135	0.000967	CcSEcCtD
Cyclosporine—Haemorrhage—Doxorubicin—liver cancer	0.000135	0.000967	CcSEcCtD
Cyclosporine—Hypoaesthesia—Doxorubicin—liver cancer	0.000135	0.000963	CcSEcCtD
Cyclosporine—Pharyngitis—Doxorubicin—liver cancer	0.000134	0.00096	CcSEcCtD
Cyclosporine—Urinary tract disorder—Doxorubicin—liver cancer	0.000134	0.000955	CcSEcCtD
Cyclosporine—Connective tissue disorder—Doxorubicin—liver cancer	0.000133	0.000951	CcSEcCtD
Cyclosporine—Angiopathy—Epirubicin—liver cancer	0.000133	0.000949	CcSEcCtD
Cyclosporine—Urethral disorder—Doxorubicin—liver cancer	0.000133	0.000948	CcSEcCtD
Cyclosporine—Mediastinal disorder—Epirubicin—liver cancer	0.000132	0.000942	CcSEcCtD
Cyclosporine—Chills—Epirubicin—liver cancer	0.000131	0.000938	CcSEcCtD
Cyclosporine—Arrhythmia—Epirubicin—liver cancer	0.000131	0.000934	CcSEcCtD
Cyclosporine—Visual impairment—Doxorubicin—liver cancer	0.000131	0.000932	CcSEcCtD
Cyclosporine—CYP3A4—liver—liver cancer	0.00013	0.000868	CbGeAlD
Cyclosporine—Alopecia—Epirubicin—liver cancer	0.000129	0.000924	CcSEcCtD
Cyclosporine—Mental disorder—Epirubicin—liver cancer	0.000128	0.000916	CcSEcCtD
Cyclosporine—CYP2D6—liver—liver cancer	0.000128	0.000854	CbGeAlD
Cyclosporine—Malnutrition—Epirubicin—liver cancer	0.000127	0.00091	CcSEcCtD
Cyclosporine—Tinnitus—Doxorubicin—liver cancer	0.000126	0.000902	CcSEcCtD
Cyclosporine—Flushing—Doxorubicin—liver cancer	0.000126	0.000898	CcSEcCtD
Cyclosporine—Flatulence—Epirubicin—liver cancer	0.000126	0.000897	CcSEcCtD
Cyclosporine—Tension—Epirubicin—liver cancer	0.000125	0.000893	CcSEcCtD
Cyclosporine—Dysgeusia—Epirubicin—liver cancer	0.000125	0.000891	CcSEcCtD
Cyclosporine—Nervousness—Epirubicin—liver cancer	0.000124	0.000884	CcSEcCtD
Cyclosporine—Angiopathy—Doxorubicin—liver cancer	0.000123	0.000878	CcSEcCtD
Cyclosporine—Muscle spasms—Epirubicin—liver cancer	0.000123	0.000875	CcSEcCtD
Cyclosporine—Mediastinal disorder—Doxorubicin—liver cancer	0.000122	0.000872	CcSEcCtD
Cyclosporine—Chills—Doxorubicin—liver cancer	0.000122	0.000868	CcSEcCtD
Cyclosporine—Arrhythmia—Doxorubicin—liver cancer	0.000121	0.000864	CcSEcCtD
Cyclosporine—Vision blurred—Epirubicin—liver cancer	0.00012	0.000858	CcSEcCtD
Cyclosporine—Alopecia—Doxorubicin—liver cancer	0.00012	0.000855	CcSEcCtD
Cyclosporine—Mental disorder—Doxorubicin—liver cancer	0.000119	0.000848	CcSEcCtD
Cyclosporine—Ill-defined disorder—Epirubicin—liver cancer	0.000118	0.000845	CcSEcCtD
Cyclosporine—Malnutrition—Doxorubicin—liver cancer	0.000118	0.000842	CcSEcCtD
Cyclosporine—Anaemia—Epirubicin—liver cancer	0.000118	0.000841	CcSEcCtD
Cyclosporine—Agitation—Epirubicin—liver cancer	0.000117	0.000836	CcSEcCtD
Cyclosporine—Flatulence—Doxorubicin—liver cancer	0.000116	0.00083	CcSEcCtD
Cyclosporine—Tension—Doxorubicin—liver cancer	0.000116	0.000826	CcSEcCtD
Cyclosporine—Dysgeusia—Doxorubicin—liver cancer	0.000115	0.000825	CcSEcCtD
Cyclosporine—Malaise—Epirubicin—liver cancer	0.000115	0.000821	CcSEcCtD
Cyclosporine—Nervousness—Doxorubicin—liver cancer	0.000115	0.000818	CcSEcCtD
Cyclosporine—Vertigo—Epirubicin—liver cancer	0.000115	0.000818	CcSEcCtD
Cyclosporine—Leukopenia—Epirubicin—liver cancer	0.000114	0.000815	CcSEcCtD
Cyclosporine—Muscle spasms—Doxorubicin—liver cancer	0.000113	0.00081	CcSEcCtD
Cyclosporine—Cough—Epirubicin—liver cancer	0.000111	0.000794	CcSEcCtD
Cyclosporine—Vision blurred—Doxorubicin—liver cancer	0.000111	0.000794	CcSEcCtD
Cyclosporine—Convulsion—Epirubicin—liver cancer	0.00011	0.000789	CcSEcCtD
Cyclosporine—Hypertension—Epirubicin—liver cancer	0.00011	0.000786	CcSEcCtD
Cyclosporine—Ill-defined disorder—Doxorubicin—liver cancer	0.000109	0.000781	CcSEcCtD
Cyclosporine—Anaemia—Doxorubicin—liver cancer	0.000109	0.000778	CcSEcCtD
Cyclosporine—Chest pain—Epirubicin—liver cancer	0.000109	0.000775	CcSEcCtD
Cyclosporine—Arthralgia—Epirubicin—liver cancer	0.000109	0.000775	CcSEcCtD
Cyclosporine—Myalgia—Epirubicin—liver cancer	0.000109	0.000775	CcSEcCtD
Cyclosporine—Agitation—Doxorubicin—liver cancer	0.000108	0.000774	CcSEcCtD
Cyclosporine—Anxiety—Epirubicin—liver cancer	0.000108	0.000772	CcSEcCtD
Cyclosporine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000108	0.00077	CcSEcCtD
Cyclosporine—Discomfort—Epirubicin—liver cancer	0.000107	0.000766	CcSEcCtD
Cyclosporine—Malaise—Doxorubicin—liver cancer	0.000106	0.000759	CcSEcCtD
Cyclosporine—Dry mouth—Epirubicin—liver cancer	0.000106	0.000758	CcSEcCtD
Cyclosporine—Vertigo—Doxorubicin—liver cancer	0.000106	0.000757	CcSEcCtD
Cyclosporine—Leukopenia—Doxorubicin—liver cancer	0.000106	0.000754	CcSEcCtD
Cyclosporine—Confusional state—Epirubicin—liver cancer	0.000105	0.000749	CcSEcCtD
Cyclosporine—Oedema—Epirubicin—liver cancer	0.000104	0.000743	CcSEcCtD
Cyclosporine—Anaphylactic shock—Epirubicin—liver cancer	0.000104	0.000743	CcSEcCtD
Cyclosporine—Infection—Epirubicin—liver cancer	0.000103	0.000738	CcSEcCtD
Cyclosporine—Cough—Doxorubicin—liver cancer	0.000103	0.000735	CcSEcCtD
Cyclosporine—Convulsion—Doxorubicin—liver cancer	0.000102	0.00073	CcSEcCtD
Cyclosporine—Nervous system disorder—Epirubicin—liver cancer	0.000102	0.000729	CcSEcCtD
Cyclosporine—Thrombocytopenia—Epirubicin—liver cancer	0.000102	0.000727	CcSEcCtD
Cyclosporine—Hypertension—Doxorubicin—liver cancer	0.000102	0.000727	CcSEcCtD
Cyclosporine—Skin disorder—Epirubicin—liver cancer	0.000101	0.000722	CcSEcCtD
Cyclosporine—Hyperhidrosis—Epirubicin—liver cancer	0.000101	0.000718	CcSEcCtD
Cyclosporine—Arthralgia—Doxorubicin—liver cancer	0.0001	0.000717	CcSEcCtD
Cyclosporine—Chest pain—Doxorubicin—liver cancer	0.0001	0.000717	CcSEcCtD
Cyclosporine—Myalgia—Doxorubicin—liver cancer	0.0001	0.000717	CcSEcCtD
Cyclosporine—Anxiety—Doxorubicin—liver cancer	0.0001	0.000715	CcSEcCtD
Cyclosporine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	9.97e-05	0.000712	CcSEcCtD
Cyclosporine—Discomfort—Doxorubicin—liver cancer	9.92e-05	0.000708	CcSEcCtD
Cyclosporine—Anorexia—Epirubicin—liver cancer	9.92e-05	0.000708	CcSEcCtD
Cyclosporine—Dry mouth—Doxorubicin—liver cancer	9.82e-05	0.000701	CcSEcCtD
Cyclosporine—Confusional state—Doxorubicin—liver cancer	9.71e-05	0.000693	CcSEcCtD
Cyclosporine—Anaphylactic shock—Doxorubicin—liver cancer	9.63e-05	0.000687	CcSEcCtD
Cyclosporine—Oedema—Doxorubicin—liver cancer	9.63e-05	0.000687	CcSEcCtD
Cyclosporine—Infection—Doxorubicin—liver cancer	9.56e-05	0.000683	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Epirubicin—liver cancer	9.48e-05	0.000677	CcSEcCtD
Cyclosporine—Nervous system disorder—Doxorubicin—liver cancer	9.44e-05	0.000674	CcSEcCtD
Cyclosporine—Thrombocytopenia—Doxorubicin—liver cancer	9.42e-05	0.000673	CcSEcCtD
Cyclosporine—Insomnia—Epirubicin—liver cancer	9.41e-05	0.000672	CcSEcCtD
Cyclosporine—Skin disorder—Doxorubicin—liver cancer	9.35e-05	0.000668	CcSEcCtD
Cyclosporine—Paraesthesia—Epirubicin—liver cancer	9.34e-05	0.000667	CcSEcCtD
Cyclosporine—Hyperhidrosis—Doxorubicin—liver cancer	9.31e-05	0.000664	CcSEcCtD
Cyclosporine—Dyspnoea—Epirubicin—liver cancer	9.27e-05	0.000662	CcSEcCtD
Cyclosporine—Somnolence—Epirubicin—liver cancer	9.25e-05	0.00066	CcSEcCtD
Cyclosporine—Anorexia—Doxorubicin—liver cancer	9.18e-05	0.000655	CcSEcCtD
Cyclosporine—ABCB1—liver—liver cancer	9.17e-05	0.000614	CbGeAlD
Cyclosporine—Dyspepsia—Epirubicin—liver cancer	9.16e-05	0.000654	CcSEcCtD
Cyclosporine—Decreased appetite—Epirubicin—liver cancer	9.04e-05	0.000646	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Epirubicin—liver cancer	8.98e-05	0.000641	CcSEcCtD
Cyclosporine—Fatigue—Epirubicin—liver cancer	8.97e-05	0.00064	CcSEcCtD
Cyclosporine—Constipation—Epirubicin—liver cancer	8.9e-05	0.000635	CcSEcCtD
Cyclosporine—Pain—Epirubicin—liver cancer	8.9e-05	0.000635	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Doxorubicin—liver cancer	8.77e-05	0.000626	CcSEcCtD
Cyclosporine—Insomnia—Doxorubicin—liver cancer	8.71e-05	0.000622	CcSEcCtD
Cyclosporine—Paraesthesia—Doxorubicin—liver cancer	8.64e-05	0.000617	CcSEcCtD
Cyclosporine—Dyspnoea—Doxorubicin—liver cancer	8.58e-05	0.000613	CcSEcCtD
Cyclosporine—Feeling abnormal—Epirubicin—liver cancer	8.57e-05	0.000612	CcSEcCtD
Cyclosporine—Somnolence—Doxorubicin—liver cancer	8.56e-05	0.000611	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Epirubicin—liver cancer	8.51e-05	0.000607	CcSEcCtD
Cyclosporine—Dyspepsia—Doxorubicin—liver cancer	8.47e-05	0.000605	CcSEcCtD
Cyclosporine—Decreased appetite—Doxorubicin—liver cancer	8.37e-05	0.000598	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Doxorubicin—liver cancer	8.31e-05	0.000593	CcSEcCtD
Cyclosporine—Fatigue—Doxorubicin—liver cancer	8.3e-05	0.000593	CcSEcCtD
Cyclosporine—Urticaria—Epirubicin—liver cancer	8.26e-05	0.00059	CcSEcCtD
Cyclosporine—Constipation—Doxorubicin—liver cancer	8.23e-05	0.000588	CcSEcCtD
Cyclosporine—Pain—Doxorubicin—liver cancer	8.23e-05	0.000588	CcSEcCtD
Cyclosporine—Abdominal pain—Epirubicin—liver cancer	8.22e-05	0.000587	CcSEcCtD
Cyclosporine—Body temperature increased—Epirubicin—liver cancer	8.22e-05	0.000587	CcSEcCtD
Cyclosporine—Feeling abnormal—Doxorubicin—liver cancer	7.93e-05	0.000566	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Doxorubicin—liver cancer	7.87e-05	0.000562	CcSEcCtD
Cyclosporine—Hypersensitivity—Epirubicin—liver cancer	7.66e-05	0.000547	CcSEcCtD
Cyclosporine—Urticaria—Doxorubicin—liver cancer	7.65e-05	0.000546	CcSEcCtD
Cyclosporine—Abdominal pain—Doxorubicin—liver cancer	7.61e-05	0.000543	CcSEcCtD
Cyclosporine—Body temperature increased—Doxorubicin—liver cancer	7.61e-05	0.000543	CcSEcCtD
Cyclosporine—Asthenia—Epirubicin—liver cancer	7.46e-05	0.000533	CcSEcCtD
Cyclosporine—Pruritus—Epirubicin—liver cancer	7.36e-05	0.000526	CcSEcCtD
Cyclosporine—Diarrhoea—Epirubicin—liver cancer	7.12e-05	0.000508	CcSEcCtD
Cyclosporine—Hypersensitivity—Doxorubicin—liver cancer	7.09e-05	0.000506	CcSEcCtD
Cyclosporine—Asthenia—Doxorubicin—liver cancer	6.91e-05	0.000493	CcSEcCtD
Cyclosporine—Dizziness—Epirubicin—liver cancer	6.88e-05	0.000491	CcSEcCtD
Cyclosporine—Pruritus—Doxorubicin—liver cancer	6.81e-05	0.000486	CcSEcCtD
Cyclosporine—Vomiting—Epirubicin—liver cancer	6.61e-05	0.000472	CcSEcCtD
Cyclosporine—Diarrhoea—Doxorubicin—liver cancer	6.59e-05	0.00047	CcSEcCtD
Cyclosporine—Rash—Epirubicin—liver cancer	6.56e-05	0.000468	CcSEcCtD
Cyclosporine—Dermatitis—Epirubicin—liver cancer	6.55e-05	0.000468	CcSEcCtD
Cyclosporine—Headache—Epirubicin—liver cancer	6.52e-05	0.000465	CcSEcCtD
Cyclosporine—Dizziness—Doxorubicin—liver cancer	6.37e-05	0.000455	CcSEcCtD
Cyclosporine—Nausea—Epirubicin—liver cancer	6.18e-05	0.000441	CcSEcCtD
Cyclosporine—Vomiting—Doxorubicin—liver cancer	6.12e-05	0.000437	CcSEcCtD
Cyclosporine—Rash—Doxorubicin—liver cancer	6.07e-05	0.000433	CcSEcCtD
Cyclosporine—Dermatitis—Doxorubicin—liver cancer	6.06e-05	0.000433	CcSEcCtD
Cyclosporine—Headache—Doxorubicin—liver cancer	6.03e-05	0.000431	CcSEcCtD
Cyclosporine—Nausea—Doxorubicin—liver cancer	5.72e-05	0.000408	CcSEcCtD
Cyclosporine—FKBP1A—Signaling Pathways—MAPK8—liver cancer	5.45e-06	3.29e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—liver cancer	5.45e-06	3.29e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—HPGDS—liver cancer	5.44e-06	3.29e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PSMA4—liver cancer	5.43e-06	3.28e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PSMD10—liver cancer	5.43e-06	3.28e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—liver cancer	5.41e-06	3.27e-05	CbGpPWpGaD
Cyclosporine—SLC10A1—Metabolism—PIK3CA—liver cancer	5.4e-06	3.26e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—PIK3CD—liver cancer	5.37e-06	3.25e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	5.37e-06	3.24e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—CYCS—liver cancer	5.36e-06	3.24e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—MTHFR—liver cancer	5.36e-06	3.24e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—SERPINE1—liver cancer	5.31e-06	3.21e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—MTHFR—liver cancer	5.31e-06	3.21e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—HPGDS—liver cancer	5.31e-06	3.21e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—GOT2—liver cancer	5.28e-06	3.19e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—GGT1—liver cancer	5.26e-06	3.18e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—GOT1—liver cancer	5.26e-06	3.18e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PPARA—liver cancer	5.26e-06	3.18e-05	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—PIK3CB—liver cancer	5.22e-06	3.15e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PPARA—liver cancer	5.21e-06	3.15e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—HRAS—liver cancer	5.19e-06	3.14e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—PIK3CG—liver cancer	5.12e-06	3.09e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	5.11e-06	3.09e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	5.1e-06	3.08e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—CPT1B—liver cancer	5.07e-06	3.07e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—GLUL—liver cancer	5.07e-06	3.07e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—PIK3CA—liver cancer	5.07e-06	3.06e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—VEGFA—liver cancer	5.03e-06	3.04e-05	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—PIK3CB—liver cancer	5e-06	3.02e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—HPGDS—liver cancer	5e-06	3.02e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—PIK3CD—liver cancer	5e-06	3.02e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	5e-06	3.02e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—STAT3—liver cancer	4.98e-06	3.01e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—IL6—liver cancer	4.97e-06	3e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—CYP2E1—liver cancer	4.97e-06	3e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—HPGDS—liver cancer	4.96e-06	3e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—PPARG—liver cancer	4.94e-06	2.99e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—ALB—liver cancer	4.94e-06	2.98e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	4.93e-06	2.98e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	4.92e-06	2.98e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—TP53—liver cancer	4.9e-06	2.96e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—NR1H4—liver cancer	4.89e-06	2.96e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—PIK3CG—liver cancer	4.86e-06	2.94e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—liver cancer	4.86e-06	2.94e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PSMD10—liver cancer	4.85e-06	2.93e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PSMA4—liver cancer	4.85e-06	2.93e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—GSTA3—liver cancer	4.81e-06	2.91e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	4.81e-06	2.91e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—RAF1—liver cancer	4.8e-06	2.9e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PSMD10—liver cancer	4.73e-06	2.86e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PSMA4—liver cancer	4.73e-06	2.86e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—GSTP1—liver cancer	4.73e-06	2.86e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—GOT2—liver cancer	4.71e-06	2.85e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—PPARG—liver cancer	4.69e-06	2.84e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—HRAS—liver cancer	4.69e-06	2.83e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—PIK3CB—liver cancer	4.68e-06	2.83e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—MTOR—liver cancer	4.68e-06	2.83e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—HMOX1—liver cancer	4.66e-06	2.82e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—CYCS—liver cancer	4.65e-06	2.81e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—MYC—liver cancer	4.63e-06	2.8e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—TGFB1—liver cancer	4.62e-06	2.79e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—GOT2—liver cancer	4.6e-06	2.78e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—AKT1—liver cancer	4.58e-06	2.77e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—GGT1—liver cancer	4.56e-06	2.76e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—GOT1—liver cancer	4.56e-06	2.76e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	4.51e-06	2.73e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PIK3CG—liver cancer	4.5e-06	2.72e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—PIK3CD—liver cancer	4.5e-06	2.72e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	4.49e-06	2.71e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—IL6—liver cancer	4.49e-06	2.71e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PIK3CG—liver cancer	4.46e-06	2.7e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PSMA4—liver cancer	4.46e-06	2.69e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PSMD10—liver cancer	4.46e-06	2.69e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—ALB—liver cancer	4.44e-06	2.68e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—CYP2E1—liver cancer	4.43e-06	2.68e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	4.43e-06	2.68e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PSMA4—liver cancer	4.42e-06	2.67e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PSMD10—liver cancer	4.42e-06	2.67e-05	CbGpPWpGaD
Cyclosporine—SLC10A1—Metabolism—AKT1—liver cancer	4.41e-06	2.67e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—GSTA4—liver cancer	4.4e-06	2.66e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—CDKN1B—liver cancer	4.39e-06	2.66e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—PIK3CB—liver cancer	4.36e-06	2.63e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PPARG—liver cancer	4.35e-06	2.63e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—GSTM1—liver cancer	4.35e-06	2.63e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—GOT2—liver cancer	4.34e-06	2.62e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—CYP2E1—liver cancer	4.33e-06	2.61e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PPARG—liver cancer	4.31e-06	2.6e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—GOT2—liver cancer	4.3e-06	2.6e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	4.29e-06	2.59e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—GSTA2—liver cancer	4.29e-06	2.59e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—PIK3CD—liver cancer	4.28e-06	2.58e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—KRAS—liver cancer	4.27e-06	2.58e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—ALB—liver cancer	4.22e-06	2.55e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—CTNNB1—liver cancer	4.15e-06	2.51e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—CYCS—liver cancer	4.15e-06	2.51e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—AKT1—liver cancer	4.14e-06	2.5e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—GSTA1—liver cancer	4.14e-06	2.5e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—CYP1A1—liver cancer	4.12e-06	2.49e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—GSTP1—liver cancer	4.1e-06	2.48e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—NAT2—liver cancer	4.09e-06	2.47e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	4.08e-06	2.47e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—CYP2E1—liver cancer	4.08e-06	2.46e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—GOT1—liver cancer	4.07e-06	2.46e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—GGT1—liver cancer	4.07e-06	2.46e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—CDKN1A—liver cancer	4.06e-06	2.45e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—CYCS—liver cancer	4.05e-06	2.45e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—CYP2E1—liver cancer	4.04e-06	2.44e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—HMOX1—liver cancer	4.04e-06	2.44e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—GGT1—liver cancer	3.97e-06	2.4e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—GOT1—liver cancer	3.97e-06	2.4e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PIK3CD—liver cancer	3.96e-06	2.39e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—PIK3CA—liver cancer	3.93e-06	2.37e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PIK3CD—liver cancer	3.92e-06	2.37e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—ALDOB—liver cancer	3.92e-06	2.37e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—PIK3CB—liver cancer	3.92e-06	2.37e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	3.91e-06	2.37e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—ALB—liver cancer	3.91e-06	2.36e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—ALB—liver cancer	3.87e-06	2.34e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—MTHFR—liver cancer	3.84e-06	2.32e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—CYCS—liver cancer	3.81e-06	2.31e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—TP53—liver cancer	3.8e-06	2.3e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—CYCS—liver cancer	3.78e-06	2.29e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PPARA—liver cancer	3.77e-06	2.28e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—GSTM1—liver cancer	3.76e-06	2.27e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—GOT1—liver cancer	3.74e-06	2.26e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—GGT1—liver cancer	3.74e-06	2.26e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—CRABP1—liver cancer	3.74e-06	2.26e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—PIK3CB—liver cancer	3.73e-06	2.25e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—GGT1—liver cancer	3.71e-06	2.24e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—GOT1—liver cancer	3.71e-06	2.24e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—GSTP1—liver cancer	3.66e-06	2.21e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—HRAS—liver cancer	3.63e-06	2.2e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—STAT3—liver cancer	3.62e-06	2.19e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—HMOX1—liver cancer	3.61e-06	2.18e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—GSTP1—liver cancer	3.57e-06	2.16e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—CYP1A1—liver cancer	3.57e-06	2.16e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—HMOX1—liver cancer	3.52e-06	2.13e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—IL6—liver cancer	3.48e-06	2.1e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PIK3CB—liver cancer	3.45e-06	2.09e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PIK3CB—liver cancer	3.42e-06	2.07e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—MYC—liver cancer	3.36e-06	2.03e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—GSTP1—liver cancer	3.36e-06	2.03e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—GSTM1—liver cancer	3.36e-06	2.03e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—TGFB1—liver cancer	3.35e-06	2.03e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—GSTP1—liver cancer	3.33e-06	2.01e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—MTHFR—liver cancer	3.33e-06	2.01e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—HMOX1—liver cancer	3.32e-06	2e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—HMOX1—liver cancer	3.29e-06	1.99e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—GSTM1—liver cancer	3.28e-06	1.98e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—HPGDS—liver cancer	3.27e-06	1.98e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PPARA—liver cancer	3.26e-06	1.97e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PIK3CG—liver cancer	3.23e-06	1.95e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—AKT1—liver cancer	3.21e-06	1.94e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—CYP1A1—liver cancer	3.18e-06	1.92e-05	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—PIK3CA—liver cancer	3.18e-06	1.92e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PPARG—liver cancer	3.11e-06	1.88e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—CYP1A1—liver cancer	3.11e-06	1.88e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—KRAS—liver cancer	3.11e-06	1.88e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—GSTM1—liver cancer	3.09e-06	1.87e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—GSTM1—liver cancer	3.06e-06	1.85e-05	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—PIK3CA—liver cancer	3.05e-06	1.84e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—MTHFR—liver cancer	2.97e-06	1.79e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.93e-06	1.77e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—CYP1A1—liver cancer	2.93e-06	1.77e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PSMA4—liver cancer	2.91e-06	1.76e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PSMD10—liver cancer	2.91e-06	1.76e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PPARA—liver cancer	2.91e-06	1.76e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—CYP1A1—liver cancer	2.9e-06	1.76e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—MTHFR—liver cancer	2.9e-06	1.75e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—PIK3CA—liver cancer	2.85e-06	1.73e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PPARA—liver cancer	2.84e-06	1.72e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PIK3CD—liver cancer	2.84e-06	1.71e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—GOT2—liver cancer	2.84e-06	1.71e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—ALB—liver cancer	2.8e-06	1.69e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PIK3CG—liver cancer	2.79e-06	1.69e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—MTHFR—liver cancer	2.73e-06	1.65e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—MTHFR—liver cancer	2.71e-06	1.64e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PPARG—liver cancer	2.7e-06	1.63e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PPARA—liver cancer	2.68e-06	1.62e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—CYP2E1—liver cancer	2.67e-06	1.61e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—PIK3CA—liver cancer	2.66e-06	1.61e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PPARA—liver cancer	2.66e-06	1.61e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—HRAS—liver cancer	2.64e-06	1.6e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.62e-06	1.58e-05	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—AKT1—liver cancer	2.6e-06	1.57e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—IL6—liver cancer	2.53e-06	1.53e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PIK3CG—liver cancer	2.49e-06	1.51e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—CYCS—liver cancer	2.49e-06	1.51e-05	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—AKT1—liver cancer	2.49e-06	1.51e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PIK3CB—liver cancer	2.47e-06	1.49e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PIK3CD—liver cancer	2.46e-06	1.48e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—GOT1—liver cancer	2.45e-06	1.48e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—GGT1—liver cancer	2.45e-06	1.48e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PIK3CG—liver cancer	2.43e-06	1.47e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—ALB—liver cancer	2.43e-06	1.47e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PPARG—liver cancer	2.41e-06	1.46e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—PIK3CA—liver cancer	2.39e-06	1.44e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.39e-06	1.44e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PPARG—liver cancer	2.35e-06	1.42e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—AKT1—liver cancer	2.33e-06	1.41e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PIK3CG—liver cancer	2.29e-06	1.39e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PIK3CG—liver cancer	2.27e-06	1.37e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—PIK3CA—liver cancer	2.27e-06	1.37e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PPARG—liver cancer	2.21e-06	1.34e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—GSTP1—liver cancer	2.2e-06	1.33e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PPARG—liver cancer	2.2e-06	1.33e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PIK3CD—liver cancer	2.19e-06	1.33e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—AKT1—liver cancer	2.17e-06	1.31e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—HMOX1—liver cancer	2.17e-06	1.31e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—ALB—liver cancer	2.16e-06	1.31e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PIK3CB—liver cancer	2.14e-06	1.29e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PIK3CD—liver cancer	2.14e-06	1.29e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—ALB—liver cancer	2.11e-06	1.28e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PIK3CA—liver cancer	2.1e-06	1.27e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PIK3CA—liver cancer	2.08e-06	1.26e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—GSTM1—liver cancer	2.02e-06	1.22e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PIK3CD—liver cancer	2.02e-06	1.22e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PIK3CD—liver cancer	2e-06	1.21e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—ALB—liver cancer	1.99e-06	1.2e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—ALB—liver cancer	1.97e-06	1.19e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—AKT1—liver cancer	1.95e-06	1.18e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—CYP1A1—liver cancer	1.92e-06	1.16e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PIK3CB—liver cancer	1.91e-06	1.16e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PIK3CB—liver cancer	1.87e-06	1.13e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—AKT1—liver cancer	1.86e-06	1.12e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—MTHFR—liver cancer	1.79e-06	1.08e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PIK3CB—liver cancer	1.76e-06	1.06e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PPARA—liver cancer	1.75e-06	1.06e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PIK3CB—liver cancer	1.74e-06	1.05e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—AKT1—liver cancer	1.72e-06	1.04e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—AKT1—liver cancer	1.7e-06	1.03e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PIK3CA—liver cancer	1.51e-06	9.11e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PIK3CG—liver cancer	1.5e-06	9.07e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PPARG—liver cancer	1.45e-06	8.75e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PIK3CD—liver cancer	1.32e-06	7.97e-06	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PIK3CA—liver cancer	1.31e-06	7.89e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—ALB—liver cancer	1.3e-06	7.87e-06	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—AKT1—liver cancer	1.23e-06	7.44e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PIK3CA—liver cancer	1.17e-06	7.04e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PIK3CB—liver cancer	1.15e-06	6.95e-06	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PIK3CA—liver cancer	1.14e-06	6.87e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PIK3CA—liver cancer	1.07e-06	6.48e-06	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—AKT1—liver cancer	1.07e-06	6.45e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PIK3CA—liver cancer	1.06e-06	6.42e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—AKT1—liver cancer	9.52e-07	5.75e-06	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—AKT1—liver cancer	9.29e-07	5.62e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—AKT1—liver cancer	8.75e-07	5.29e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—AKT1—liver cancer	8.68e-07	5.25e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PIK3CA—liver cancer	7.01e-07	4.23e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—AKT1—liver cancer	5.72e-07	3.46e-06	CbGpPWpGaD
